Target intelligence / Profile preview

Urethral sphincter

Molecular classification
Other
01

Overview

The urethral sphincter is a complex anatomical structure essential for maintaining urinary continence and facilitating controlled micturition. It is composed of two distinct parts: the internal urethral sphincter, which consists of smooth muscle under involuntary autonomic control, and the external urethral sphincter, which is made of striated muscle under voluntary somatic control (StatPearls, 2023). The internal sphincter is densely populated with alpha-1A adrenergic receptors, which maintain contraction to prevent leakage, while the external sphincter is innervated by the pudendal nerve and utilizes nicotinic acetylcholine receptors at the neuromuscular junction (NIH, 2022). Clinical conditions such as stress urinary incontinence, benign prostatic hyperplasia (BPH), and detrusor-sphincter dyssynergia arise from the dysfunction of these muscular components or their neural pathways. Pharmacological treatments target the specific receptors within the sphincter; for instance, alpha-blockers like tamsulosin are used to relax the internal sphincter in men with prostatic obstruction, whereas duloxetine may be used to increase external sphincter tone by enhancing neurotransmitter levels in Onuf's nucleus (PubMed, 2021). Because the urethral sphincter is a multi-tissue organ rather than a single protein or receptor, it is categorized as a therapeutic site rather than a specific molecular target.

Other names
Sphincter urethraeUrinary sphincterMusculus sphincter urethraeUrethral sphincter complex
02

Mechanism of action

Alpha-1 adrenergic receptor antagonism (relaxation of internal sphincter); Serotonin-norepinephrine reuptake inhibition (enhancement of external sphincter tone via Onuf's nucleus); Inhibition of acetylcholine release (paralysis of sphincter muscle); Alpha-1 adrenergic receptor agonism (contraction of internal sphincter).

03

Biological functions

Urinary continenceMicturition controlSemen emission regulation
04

Disease associations

Urinary incontinenceBenign prostatic hyperplasiaDetrusor-sphincter dyssynergiaNeurogenic bladderProstate cancer (post-surgical complications)
05

Safety considerations

Orthostatic hypotensionRetrograde ejaculationUrinary retentionDizzinessPotential for systemic botulism-like effects with local injection
06

Interacting drugs

Tamsulosin

8 more in the full profile.

07

Biomarkers

Maximum urethral closure pressure (MUCP)Urethral pressure profile (UPP)Valsalva leak point pressure (VLPP)Sphincter electromyography (EMG)

Beyond the preview

Go deeper on Urethral sphincter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urethral sphincter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call